Patricia Cash
Overview
Explore the profile of Patricia Cash including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Backes A, Cash P, Jordan J
Consult Pharm
. 2017 Oct;
32(10):13-24.
PMID: 29021009
Objective: To highlight the need to optimize the use of discharge medication lists in nursing facilities. Setting: In January 2014, the care transitions (CT) pharmacists at Frederick Memorial Hospital, Frederick,...
2.
Backes A, Cash P, Jordan J
Consult Pharm
. 2016 Sep;
31(9):493-9.
PMID: 27636873
Objective: To highlight the need to optimize the use of discharge medication lists in nursing facilities. Setting: In January 2014, the care transitions (CT) pharmacists at Frederick Memorial Hospital, Frederick,...
3.
Cao M, Mo W, Shannon A, Wei Z, Washabaugh M, Cash P
PDA J Pharm Sci Technol
. 2016 Apr;
70(6):490-507.
PMID: 27091886
Lay Abstract: Aspartate isomerization is a common post-translational modification of recombinant proteins during manufacture process and storage. Isomerization in the complementarity-determining regions (CDRs) of a monoclonal antibody A (mAb-A) has...
4.
Backes A, Cash P, Jordan J
Consult Pharm
. 2016 Jan;
31(1):13-24.
PMID: 26803087
Objective: To describe two innovative practice models that expand pharmacy services within a nursing facility's transitional care unit (TCU) to meet the needs of patients transitioning to subacute or community...
5.
Corvari V, Narhi L, Spitznagel T, Afonina N, Cao S, Cash P, et al.
Biologicals
. 2015 Sep;
43(6):457-73.
PMID: 26324466
Measurement and characterization of subvisible particles (including proteinaceous and non-proteinaceous particulate matter) is an important aspect of the pharmaceutical development process for biotherapeutics. Health authorities have increased expectations for subvisible...
6.
Lamb D, Lei Q, Hakim N, Rizzo S, Cash P
Anal Biochem
. 2005 Mar;
338(2):263-9.
PMID: 15745746
Meningococcal polysaccharides are medically important molecules and are the active components of vaccines against Neisseria meningiditis serogroups A, C, W135, and Y. This study demonstrates that free solution capillary zone...
7.
Cai X, Lei Q, Lamb D, Shannon A, Jacoby J, Kruk J, et al.
Anal Chem
. 2004 Dec;
76(24):7387-90.
PMID: 15595884
Hydrogen peroxide has been used to cleave the native Neisseria meningiditis polysaccharide (PS) from mega-Dalton molecular weight to a smaller size (approximately 20 kDa) depolymerized polysaccharide. The polysaccharide was examined...
8.
Lei Q, Lamb D, Shannon A, Cai X, Heller R, Huang M, et al.
J Chromatogr B Analyt Technol Biomed Life Sci
. 2004 Nov;
813(1-2):103-12.
PMID: 15556522
An LC-MS/MS method for determination of the break down product of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide (EDC) urea derivative, EDU, has been developed and validated for monitoring the residual coupling reagents. Results indicate...
9.
Lei Q, Lamb D, Heller R, Shannon A, Ryall R, Cash P
Anal Biochem
. 2002 Nov;
310(1):122-4.
PMID: 12413482
No abstract available.